Equities analysts predict that Envision Healthcare Corporation (NYSE:EVHC) will announce $2.00 billion in sales for the current quarter, according to Zacks Investment Research. Eight analysts have provided estimates for Envision Healthcare Corporation’s earnings, with the lowest sales estimate coming in at $1.94 billion and the highest estimate coming in at $2.06 billion. Envision Healthcare Corporation reported sales of $822.22 million during the same quarter last year, which suggests a positive year over year growth rate of 143.2%. The business is scheduled to announce its next earnings report on Tuesday, November 7th.

On average, analysts expect that Envision Healthcare Corporation will report full year sales of $2.00 billion for the current financial year, with estimates ranging from $7.78 billion to $8.01 billion. For the next fiscal year, analysts anticipate that the company will post sales of $8.73 billion per share, with estimates ranging from $8.28 billion to $9.06 billion. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that cover Envision Healthcare Corporation.

Envision Healthcare Corporation (NYSE:EVHC) last posted its quarterly earnings results on Monday, August 7th. The company reported $0.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.75 by $0.04. The company had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.96 billion. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. Envision Healthcare Corporation’s revenue was up 156.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.34 earnings per share.

A number of brokerages recently commented on EVHC. Jefferies Group LLC set a $71.00 price objective on shares of Envision Healthcare Corporation and gave the company a “buy” rating in a research report on Thursday, August 24th. BidaskClub cut shares of Envision Healthcare Corporation from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 17th. Zacks Investment Research upgraded shares of Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a research note on Friday, August 11th. Mizuho reduced their target price on shares of Envision Healthcare Corporation from $65.00 to $57.00 and set a “neutral” rating for the company in a research note on Wednesday, August 9th. Finally, Cantor Fitzgerald reiterated a “buy” rating on shares of Envision Healthcare Corporation in a research note on Monday, July 24th. One analyst has rated the stock with a sell rating, two have issued a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. Envision Healthcare Corporation currently has a consensus rating of “Buy” and an average target price of $71.56.

In other news, insider Robert Jon Coward sold 1,500 shares of the business’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $62.69, for a total value of $94,035.00. Following the completion of the sale, the insider now directly owns 97,863 shares in the company, valued at $6,135,031.47. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 3.10% of the stock is owned by insiders.

Several institutional investors have recently modified their holdings of EVHC. Nisa Investment Advisors LLC lifted its stake in shares of Envision Healthcare Corporation by 14,372.5% in the first quarter. Nisa Investment Advisors LLC now owns 28,945 shares of the company’s stock worth $1,775,000 after buying an additional 28,745 shares during the last quarter. Korea Investment CORP acquired a new stake in shares of Envision Healthcare Corporation in the first quarter worth $141,000. Profund Advisors LLC lifted its stake in shares of Envision Healthcare Corporation by 9.8% in the first quarter. Profund Advisors LLC now owns 4,861 shares of the company’s stock worth $298,000 after buying an additional 432 shares during the last quarter. ProShare Advisors LLC lifted its stake in shares of Envision Healthcare Corporation by 1.7% in the first quarter. ProShare Advisors LLC now owns 11,780 shares of the company’s stock worth $722,000 after buying an additional 192 shares during the last quarter. Finally, Glen Harbor Capital Management LLC lifted its stake in shares of Envision Healthcare Corporation by 164.0% in the first quarter. Glen Harbor Capital Management LLC now owns 6,580 shares of the company’s stock worth $404,000 after buying an additional 4,088 shares during the last quarter. Institutional investors and hedge funds own 64.75% of the company’s stock.

Envision Healthcare Corporation (NYSE:EVHC) traded down 4.24% during trading on Friday, reaching $48.77. 2,290,382 shares of the company’s stock were exchanged. Envision Healthcare Corporation has a 52 week low of $48.26 and a 52 week high of $74.75. The stock’s market capitalization is $5.71 billion. The company’s 50 day moving average price is $54.49 and its 200-day moving average price is $58.86.

TRADEMARK VIOLATION WARNING: This piece was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/09/06/brokerages-anticipate-envision-healthcare-corporation-evhc-will-announce-quarterly-sales-of-2-00-billion.html.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Get a free copy of the Zacks research report on Envision Healthcare Corporation (EVHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related stocks with our FREE daily email newsletter.